Humane Genomics
Pre-clinicalHumane Genomics develops cancer therapies by engineering cancer-killing RNA viruses using a synthetic biology platform.
Founded
2018
Focus
Viral Technology
About
Humane Genomics develops cancer therapies by engineering cancer-killing RNA viruses using a synthetic biology platform.
Funding History
2Total raised: $15.5M
Series A$12MKdT VenturesApr 15, 2022
Seed$3.5MKdT VenturesSep 15, 2020
Company Info
TypePrivate
Founded2018
LocationSan Diego, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile